Intralesional vinblastine injections for treatment of Classic Kaposi sarcoma in diabetic patients

Camilla Vassallo; Andrea Carugno; Federica Derlino; Olga Ciocca; Valeria Brazzelli; Giovanni Borroni

Intralesional vinblastine injections for treatment of Classic Kaposi sarcoma in diabetic patients

Camilla Vassallo, Andrea Carugno, Federica Derlino, Olga Ciocca, Valeria Brazzelli, Giovanni Borroni

IRCCS Fondazione Policlinico San Matteo

Research output: Contribution to journal › Article › peer-review

Abstract

Classic Kaposi sarcoma (KS) usually is a localized and slowly progressing disease that mainly affects elderly patients; therefore, local treatment generally is recommended. In this study, we evaluated the clinical efficacy of intralesional vinblastine (VNB) for the treatment of classic KS in 6 participants with type 2 diabetes mellitus. Results indicated that intralesional VNB injections may be an effective alternative treatment of classic KS in diabetic patients.

Original language	English
Pages (from-to)	E28-E34
Journal	Cutis
Volume	95
Issue number	5
Publication status	Published - 2015

ASJC Scopus subject areas

Dermatology

Cite this

@article{dfbd283a524541a2978f6fcd6b529f0c,

title = "Intralesional vinblastine injections for treatment of Classic Kaposi sarcoma in diabetic patients",

abstract = "Classic Kaposi sarcoma (KS) usually is a localized and slowly progressing disease that mainly affects elderly patients; therefore, local treatment generally is recommended. In this study, we evaluated the clinical efficacy of intralesional vinblastine (VNB) for the treatment of classic KS in 6 participants with type 2 diabetes mellitus. Results indicated that intralesional VNB injections may be an effective alternative treatment of classic KS in diabetic patients.",

author = "Camilla Vassallo and Andrea Carugno and Federica Derlino and Olga Ciocca and Valeria Brazzelli and Giovanni Borroni",

year = "2015",

language = "English",

volume = "95",

pages = "E28--E34",

journal = "Cutis",

issn = "0011-4162",

publisher = "Quadrant Healthcom Inc.",

number = "5",

}

TY - JOUR

T1 - Intralesional vinblastine injections for treatment of Classic Kaposi sarcoma in diabetic patients

AU - Vassallo, Camilla

AU - Carugno, Andrea

AU - Derlino, Federica

AU - Ciocca, Olga

AU - Brazzelli, Valeria

AU - Borroni, Giovanni

PY - 2015

Y1 - 2015

N2 - Classic Kaposi sarcoma (KS) usually is a localized and slowly progressing disease that mainly affects elderly patients; therefore, local treatment generally is recommended. In this study, we evaluated the clinical efficacy of intralesional vinblastine (VNB) for the treatment of classic KS in 6 participants with type 2 diabetes mellitus. Results indicated that intralesional VNB injections may be an effective alternative treatment of classic KS in diabetic patients.

AB - Classic Kaposi sarcoma (KS) usually is a localized and slowly progressing disease that mainly affects elderly patients; therefore, local treatment generally is recommended. In this study, we evaluated the clinical efficacy of intralesional vinblastine (VNB) for the treatment of classic KS in 6 participants with type 2 diabetes mellitus. Results indicated that intralesional VNB injections may be an effective alternative treatment of classic KS in diabetic patients.

UR - http://www.scopus.com/inward/record.url?scp=84975882705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975882705&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84975882705

VL - 95

SP - E28-E34

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 5

ER -

Intralesional vinblastine injections for treatment of Classic Kaposi sarcoma in diabetic patients

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this